Turnstone Biologics
About:
Turnstone Biologics is a privately-held clinical stage biotech company.
Website: http://www.turnstonebio.com/
Top Investors: OrbiMed, F-Prime Capital, Takeda, Northleaf Capital Partners, Versant Ventures
Description:
Turnstone Biologics is a privately-held clinical-stage biotech company. Turnstone Biologics’ mission is to deliver breakthrough cancer immunotherapies by advancing two leading and complementary platforms targeting tumor immunity, to improve survival for people with cancer.
Total Funding Amount:
$133M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
La Jolla, California, United States
Founded Date:
2015-01-01
Contact Email:
info(AT)turnstonebio.com
Founders:
Brian Lichty, David Stojdl, John Bell
Number of Employees:
101-250
Last Funding Date:
2021-07-14
IPO Status:
Public
Industries:
© 2025 bioDAO.ai